• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于增强脑肿瘤容积 MRI 响应评估的新方法。

A novel method for volumetric MRI response assessment of enhancing brain tumors.

机构信息

Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.

出版信息

PLoS One. 2011 Jan 26;6(1):e16031. doi: 10.1371/journal.pone.0016031.

DOI:10.1371/journal.pone.0016031
PMID:21298088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3027624/
Abstract

Current radiographic response criteria for brain tumors have difficulty describing changes surrounding postoperative resection cavities. Volumetric techniques may offer improved assessment, however usually are time-consuming, subjective and require expert opinion and specialized magnetic resonance imaging (MRI) sequences. We describe the application of a novel volumetric software algorithm that is nearly fully automated and uses standard T1 pre- and post-contrast MRI sequences. T1-weighted pre- and post-contrast images are automatically fused and normalized. The tumor region of interest is grossly outlined by the user. An atlas of the nasal mucosa is automatically detected and used to normalize levels of enhancement. The volume of enhancing tumor is then automatically calculated. We tested the ability of our method to calculate enhancing tumor volume with resection cavity collapse and when the enhancing tumor is obscured by subacute blood in a resection cavity. To determine variability in results, we compared narrowly-defined tumor regions with tumor regions that include adjacent meningeal enhancement and also compared different contrast enhancement threshold levels used for the automatic calculation of enhancing tumor volume. Our method quantified enhancing tumor volume despite resection cavity collapse. It detected tumor volume increase in the midst of blood products that incorrectly caused decreased measurements by other techniques. Similar trends in volume changes across scans were seen with inclusion or exclusion of meningeal enhancement and despite different automated thresholds for tissue enhancement. Our approach appears to overcome many of the challenges with response assessment of enhancing brain tumors and warrants further examination and validation.

摘要

目前,用于脑肿瘤的放射学反应标准在描述术后切除腔周围的变化方面存在困难。体积技术可能提供更好的评估,但通常耗时、主观,需要专家意见和专门的磁共振成像(MRI)序列。我们描述了一种新型的自动、几乎完全自动化的体积软件算法的应用,该算法使用标准的 T1 对比前后 MRI 序列。T1 加权前后图像自动融合和归一化。用户粗略勾勒肿瘤感兴趣区。自动检测鼻黏膜图谱并用于增强水平的归一化。然后自动计算增强肿瘤的体积。我们测试了我们的方法在切除腔塌陷和增强肿瘤被切除腔内亚急性血液遮挡时计算增强肿瘤体积的能力。为了确定结果的可变性,我们比较了狭窄定义的肿瘤区域与包括相邻脑膜增强的肿瘤区域,还比较了自动计算增强肿瘤体积时使用的不同对比增强阈值水平。尽管切除腔塌陷,我们的方法仍能定量增强肿瘤的体积。它检测到在血液产物中肿瘤体积的增加,而其他技术会错误地导致测量值降低。包括或排除脑膜增强以及不同的组织增强自动阈值对体积变化的相似趋势在不同扫描中均可见。我们的方法似乎克服了评估增强脑肿瘤反应的许多挑战,值得进一步研究和验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/1b2c9c376873/pone.0016031.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/b8042eece0ce/pone.0016031.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/4e47941e77a8/pone.0016031.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/1ddc26154136/pone.0016031.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/4333f10ae0a6/pone.0016031.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/33e053de7fcf/pone.0016031.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/1b2c9c376873/pone.0016031.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/b8042eece0ce/pone.0016031.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/4e47941e77a8/pone.0016031.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/1ddc26154136/pone.0016031.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/4333f10ae0a6/pone.0016031.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/33e053de7fcf/pone.0016031.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/3027624/1b2c9c376873/pone.0016031.g006.jpg

相似文献

1
A novel method for volumetric MRI response assessment of enhancing brain tumors.一种用于增强脑肿瘤容积 MRI 响应评估的新方法。
PLoS One. 2011 Jan 26;6(1):e16031. doi: 10.1371/journal.pone.0016031.
2
Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.磁共振成像容积评估寡突胶质细胞瘤对比增强和切除范围。
J Neurosurg. 2012 Jun;116(6):1172-81. doi: 10.3171/2012.2.JNS102032. Epub 2012 Mar 16.
3
A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma.一种用于增强型胶质母细胞瘤容积磁共振成像评估的新颖、可重复且客观的方法。
J Neurosurg. 2014 Sep;121(3):536-42. doi: 10.3171/2014.4.JNS121952. Epub 2014 Jul 18.
4
5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.5-氨基乙酰丙酸完整切除超出了磁共振对比增强:胶质母细胞瘤手术中切除范围的移位校正体积分析
Acta Neurochir (Wien). 2014 Feb;156(2):305-12; discussion 312. doi: 10.1007/s00701-013-1906-7. Epub 2013 Oct 25.
5
Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.基于人工神经网络的 MRI 神经肿瘤学中肿瘤自动定量反应评估:多中心回顾性研究。
Lancet Oncol. 2019 May;20(5):728-740. doi: 10.1016/S1470-2045(19)30098-1. Epub 2019 Apr 2.
6
Alpha shape theory for 3D visualization and volumetric measurement of brain tumor progression using magnetic resonance images.利用磁共振图像进行脑肿瘤进展的三维可视化和体积测量的阿尔法形状理论。
Magn Reson Imaging. 2015 Jul;33(6):787-803. doi: 10.1016/j.mri.2015.03.008. Epub 2015 Apr 9.
7
Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery.内窥镜辅助荧光引导切除术可实现胶质母细胞瘤手术的超全切除。
Neurosurg Focus. 2021 Jan;50(1):E3. doi: 10.3171/2020.10.FOCUS20560.
8
Increased Delay Between Gadolinium Chelate Administration and T1-Weighted Magnetic Resonance Imaging Acquisition Increases Contrast-Enhancing Tumor Volumes and T1 Intensities in Brain Tumor Patients.钆螯合物给药与 T1 加权磁共振成像采集之间的延迟增加会增加脑肿瘤患者的增强肿瘤体积和 T1 强度。
Invest Radiol. 2018 Apr;53(4):223-228. doi: 10.1097/RLI.0000000000000432.
9
MRI assessment of relapsed glioblastoma during treatment with bevacizumab: volumetric measurement of enhanced and FLAIR lesions for evaluation of response and progression--a pilot study.MRI 评估贝伐单抗治疗复发性胶质母细胞瘤:增强和 FLAIR 病变的容积测量用于评估反应和进展——一项初步研究。
Eur J Radiol. 2013 May;82(5):e240-5. doi: 10.1016/j.ejrad.2012.12.018. Epub 2013 Feb 9.
10
Semi-automated brain tumor and edema segmentation using MRI.使用磁共振成像(MRI)进行半自动脑肿瘤和水肿分割
Eur J Radiol. 2005 Oct;56(1):12-9. doi: 10.1016/j.ejrad.2005.03.028.

引用本文的文献

1
Volumetric analysis: Rethinking brain metastases response assessment.容积分析:重新思考脑转移瘤的疗效评估
Neurooncol Adv. 2023 Dec 10;6(1):vdad161. doi: 10.1093/noajnl/vdad161. eCollection 2024 Jan-Dec.
2
Evaluation of RANO Criteria for the Assessment of Tumor Progression for Lower-Grade Gliomas.低级别胶质瘤肿瘤进展评估的RANO标准评价
Cancers (Basel). 2023 Jun 21;15(13):3274. doi: 10.3390/cancers15133274.
3
Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images.

本文引用的文献

1
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.高级别胶质瘤更新后的反应评估标准:神经肿瘤学工作组的反应评估。
J Clin Oncol. 2010 Apr 10;28(11):1963-72. doi: 10.1200/JCO.2009.26.3541. Epub 2010 Mar 15.
2
End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria.胶质瘤的终点评估:新型治疗方法限制了经典麦克唐纳标准的实用性。
J Clin Oncol. 2009 Jun 20;27(18):2905-8. doi: 10.1200/JCO.2009.22.4998. Epub 2009 May 18.
3
The parametric response map is an imaging biomarker for early cancer treatment outcome.
利用磁共振图像半自动分割评估颅内恶性肿瘤的免疫治疗反应。
Front Immunol. 2022 Dec 14;13:1029656. doi: 10.3389/fimmu.2022.1029656. eCollection 2022.
4
Quality measures for fully automatic CT histogram-based fat estimation on a corpse sample.基于尸体样本的全自动化 CT 直方图的脂肪定量的质量评估。
Sci Rep. 2022 Nov 23;12(1):20147. doi: 10.1038/s41598-022-24358-4.
5
Ellipsoid calculations versus manual tumor delineations for glioblastoma tumor volume evaluation.椭球计算与手动肿瘤勾画在胶质母细胞瘤肿瘤体积评估中的比较。
Sci Rep. 2022 Jun 22;12(1):10502. doi: 10.1038/s41598-022-13739-4.
6
Evaluation of Response to Immune Checkpoint Inhibitors Using a Radiomics, Lesion-Level Approach.使用基于影像组学的病灶水平方法评估对免疫检查点抑制剂的反应
Cancers (Basel). 2021 Dec 1;13(23):6050. doi: 10.3390/cancers13236050.
7
Standardized MRI assessment of high-grade glioma response: a review of the essential elements and pitfalls of the RANO criteria.高级别胶质瘤反应的标准化MRI评估:RANO标准的基本要素与陷阱综述
Neurooncol Pract. 2016 Mar;3(1):59-67. doi: 10.1093/nop/npv023. Epub 2015 Jul 12.
8
Impact on survival of early tumor growth between surgery and radiotherapy in patients with de novo glioblastoma.新诊断胶质母细胞瘤患者手术和放疗之间早期肿瘤生长对生存的影响。
J Neurooncol. 2019 May;142(3):489-497. doi: 10.1007/s11060-019-03120-3. Epub 2019 Feb 19.
9
Glioma response assessment: Classic pitfalls, novel confounders, and emerging imaging tools.胶质瘤反应评估:经典陷阱、新型混杂因素及新兴成像工具
Br J Radiol. 2019 Feb;92(1094):20180730. doi: 10.1259/bjr.20180730. Epub 2018 Nov 14.
10
Current concepts and challenges in the radiologic assessment of brain tumors in children: part 2.儿童脑肿瘤放射学评估的当前概念与挑战:第2部分
Pediatr Radiol. 2018 Dec;48(13):1844-1860. doi: 10.1007/s00247-018-4232-7. Epub 2018 Sep 13.
参数反应图是一种用于早期癌症治疗结果的成像生物标志物。
Nat Med. 2009 May;15(5):572-6. doi: 10.1038/nm.1919. Epub 2009 Apr 19.
4
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).实体瘤新的疗效评价标准:修订的RECIST指南(第1.1版)
Eur J Cancer. 2009 Jan;45(2):228-47. doi: 10.1016/j.ejca.2008.10.026.
5
Response criteria for glioma.胶质瘤的疗效评估标准。
Nat Clin Pract Oncol. 2008 Nov;5(11):634-44. doi: 10.1038/ncponc1204. Epub 2008 Aug 19.
6
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.功能扩散图谱作为高级别胶质瘤的早期影像生物标志物:与传统放射学反应及总生存期的相关性
J Clin Oncol. 2008 Jul 10;26(20):3387-94. doi: 10.1200/JCO.2007.15.2363. Epub 2008 Jun 9.
7
Assessment of breast cancer response to neoadjuvant chemotherapy: is volumetric MRI a reliable tool?评估乳腺癌对新辅助化疗的反应:容积磁共振成像是否是一种可靠的工具?
Eur J Radiol. 2009 Jul;71(1):82-8. doi: 10.1016/j.ejrad.2008.03.021. Epub 2008 May 9.
8
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.恶性胶质瘤假性进展的临床特征、机制及处理
Lancet Oncol. 2008 May;9(5):453-61. doi: 10.1016/S1470-2045(08)70125-6.
9
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.O-6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化状态可预测新诊断的胶质母细胞瘤患者同步放化疗后假性进展的发生率及预后。
J Clin Oncol. 2008 May 1;26(13):2192-7. doi: 10.1200/JCO.2007.14.8163.
10
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology.同步放化疗后疾病进展或假性进展:神经肿瘤学中的陷阱
Neuro Oncol. 2008 Jun;10(3):361-7. doi: 10.1215/15228517-2008-008. Epub 2008 Apr 9.